Cite
Supplementary Figure 4 from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
MLA
Douglas S. Tyler, et al. Supplementary Figure 4 from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....72702db2a95eb0d91fc72bc27cf24fd3&authtype=sso&custid=ns315887.
APA
Douglas S. Tyler, Francis Ali-Osman, Henry S. Friedman, John A. Olson, Yasunori Yoshimoto, Jin Soo Yoo, Insuk Sohn, Sin-Ho Jung, & Christina K. Augustine. (2023). Supplementary Figure 4 from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma.
Chicago
Douglas S. Tyler, Francis Ali-Osman, Henry S. Friedman, John A. Olson, Yasunori Yoshimoto, Jin Soo Yoo, Insuk Sohn, Sin-Ho Jung, and Christina K. Augustine. 2023. “Supplementary Figure 4 from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....72702db2a95eb0d91fc72bc27cf24fd3&authtype=sso&custid=ns315887.